Internal Medicine
Study Commentary: Dexamethasone & COVID – A Study in Immunopathology, Evidence-based Medicine, and Ourselves
24 Jun, 2020 | 03:26h | UTC
Interactive Atlas: Inside the Coronavirus
24 Jun, 2020 | 03:32h | UTCInside the Coronavirus – Scientific American
“What scientists know about the inner workings of the pathogen that has infected the world”.
Related Commentary on Twitter
https://twitter.com/ESchattner/status/1275526658364182529
[Preprint] Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report
23 Jun, 2020 | 08:47h | UTCEffect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report – medRxiv
Article press release from a few days ago: Dexamethasone Reduces Death by Up to One Third in Patients with Severe COVID-19
Related Commentary on Twitter
Kudos to @MartinLandray and team, including all patients, practitioners, administrators, funders & researchers. Amazing study. This is the new standard about how to move quickly, thoughtfully and effectively in research. Now @medrxivpreprint. Pls comment. https://t.co/0MBY13Uxvc pic.twitter.com/fFx3166nCJ
— Harlan Krumholz (@hmkyale) June 22, 2020
Updated: IDSA Guidelines on the Treatment and Management of Patients with COVID-19
23 Jun, 2020 | 08:45h | UTC
IDSA has just released updates to its COVID-19 Treatment and Management Guidelines. New recommendations have been made on the use of #remdesivir, #hydroxychloroquine, hydroxychloroquine + #azithromycin, #convalescentplasma for treatment & #famotidine. 📄 https://t.co/H4KGct57fZ pic.twitter.com/hUuU1aYS4r
— IDSA (@IDSAInfo) June 23, 2020
A Compendium Answering 150 Questions on COVID‐19 and SARS‐CoV‐2
23 Jun, 2020 | 08:38h | UTCA compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2 – Allergy
AHA/AMA Joint Policy Statement: Self-Measured Blood Pressure Monitoring at Home
23 Jun, 2020 | 08:24h | UTC
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
23 Jun, 2020 | 08:19h | UTC
Saturated Fats and Health: A Reassessment and Proposal for Food-based Recommendations: JACC State-of-the-Art Review
23 Jun, 2020 | 08:22h | UTC
Podcast: Interstitial Lung Disease
23 Jun, 2020 | 08:16h | UTC#221 Interstitial Lung Disease with Erin Narewski DO – The Curbsiders Internal Medicine Podcast
Study: Coronavirus Antibodies Can Disappear After a Few Months
21 Jun, 2020 | 23:46h | UTCClinical and immunological assessment of asymptomatic SARS-CoV-2 infections – Nature Medicine
Commentaries: Chinese study: Antibodies in COVID-19 patients fade quickly – CIDRAP AND Coronavirus antibodies may disappear 2 to 3 months after people recover, a new study found – Business Insider AND New insights can change everything we know about coronavirus antibodies – BGR – News Beezer AND Expert reaction to study looking at the immune response of 37 asymptomatic people with confirmed SARS-CoV-2 infection – Science Media Centre AND You May Have Antibodies After Coronavirus Infection. But Not for Long – The New York Times
NIH Halts Clinical Trial of Hydroxychloroquine
21 Jun, 2020 | 23:44h | UTCNIH halts clinical trial of hydroxychloroquine – NIH News Releases
Covid-19: Another Study Shows ACEI/ARB Use is Not Associated with Increased Mortality Risk
21 Jun, 2020 | 23:40h | UTCEditorial: Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19 – JAMA
Characteristics Associated with Out-of-Hospital Cardiac Arrests and Resuscitations During the Covid-19 Pandemic in New York City
21 Jun, 2020 | 23:33h | UTCEditorial: Heroism in the Face of the COVID-19 Pandemic
Related Commentary on Twitter
A doubling (and >4X at peak) of out-of-hospital cardiac arrests, with 90% of leading to deaths, in New York City during its #COVID19 outbreak @JAMACardio https://t.co/PbtzAvCoNY likely reflects collateral damage—fear of medical attention (covid & cardiac) + direct heart impact pic.twitter.com/jJwF1hF61T
— Eric Topol (@EricTopol) June 19, 2020
Systematic Review: COVID-19 Pandemic and Mental Health Consequences
21 Jun, 2020 | 23:31h | UTCCommentary: COVID-19 may have consequences for mental health – University of Copenhagen
Prevalence of Taste and Smell Dysfunction in Coronavirus Disease 2019
21 Jun, 2020 | 23:29h | UTC
Related Commentary on Twitter
Prevalence of Taste and Smell Dysfunction #COVID19
This survey study published @JAMANetwork of 204 patients with coronavirus disease 2019 found that taste reduction was present in 55.4% of patients, whereas smell reduction was present in 41.7% of patientshttps://t.co/aQ45uD6GAD— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) June 18, 2020
[Abstract Only] Randomized Trial: Systematic vs. Test-Guided Treatment for Tuberculosis in Patients with Advanced HIV
21 Jun, 2020 | 23:24h | UTCSystematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Empiric systemic tuberculosis treatment not superior to test-guided treatment for HIV patients – 2 Minute Medicine AND Empirical TB Treatment Fails in Patients with Advanced HIV – Physician’s Weekly
Association of Azithromycin Use with Cardiovascular Mortality
21 Jun, 2020 | 23:21h | UTCAssociation of Azithromycin Use With Cardiovascular Mortality – JAMA Network Open
Commentary: Azithromycin tied to higher risk of death – CIDRAP
ACP: Advice on Use of N95, Surgical, and Cloth Masks to Prevent COVID-19
19 Jun, 2020 | 09:47h | UTC
Perspective: COVID-19 Is Far More Lethal Than Influenza
19 Jun, 2020 | 09:43h | UTCCOVID-19 Is Far More Lethal Than Influenza – Medium
Challenges of “Return to Work” in an Ongoing Pandemic
19 Jun, 2020 | 09:44h | UTCChallenges of “Return to Work” in an Ongoing Pandemic – New England Journal of Medicine
[Preprint] Limited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial Coinfection
19 Jun, 2020 | 09:36h | UTCLimited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial Coinfection – medRxiv
Related Commentary on Twitter
Limited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial Coinfection | pre-peer review in @medrxivpreprint colleagues from @UTSWInfDis remind us that bacterial co-infections are UNCOMMON in #Covid_19 so don’t use antibiotics! https://t.co/dpNLRZiOZn
— Carlos del Rio (@CarlosdelRio7) June 18, 2020
Depression, Pain, Breathing Problems—and That’s After Surviving COVID-19
19 Jun, 2020 | 09:37h | UTCDepression, Pain, Breathing Problems—and That’s After Surviving COVID-19 – Global Health NOW
Related: Report Suggests Some ‘Mildly Symptomatic’ Covid-19 Patients Endure Serious Long-Term Effects (other commentaries on the subject)
Randomized Trial: Tranexamic Acid Does Not Reduce Death from Gastrointestinal Bleeding
19 Jun, 2020 | 09:32h | UTCInvited Commentary: Tranexamic acid for severe gastrointestinal bleeding – The Lancet
Blood Type Linked to Outcomes in Covid-19 Patients: Type O May Be Protective and Type A May Increase Risk
18 Jun, 2020 | 09:12h | UTCCommentary: Study ties blood type to COVID-19 risk; O may help, A hurt – Associated Press
Study: Face Mask Policies May Have Averted as Many as 230,000–450,000 Covid-19 Cases in the US
18 Jun, 2020 | 09:10h | UTCCommentary: Face mask requirements may have prevented 450,000 coronavirus cases – BGR
Related Commentary on Twitter
New study in @Health_Affairs: data suggest that the 15 states and DC that mandated mask-wearing in public between 4/8 and 5/15 averted as many as 230,000–450,000 #covid19 cases.
Wear your mask. Keep your distance. It's not politics; it's science. https://t.co/JUQNJg5DqH
— Zeke Emanuel (@ZekeEmanuel) June 17, 2020